Russia Is a Potemkin Superpower Opinion Paul

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
246
Russia Is a Potemkin Superpower

Opinion
Paul Krugman

Feb. 28, 2022


Beware, Vladimir Putin: Spring is coming. And when it does, you’ll lose much of whatever leverage you had left.

Before Putin invaded Ukraine, I might have described the Russian Federation as a medium-size power punching above its weight in part by exploiting Western divisions and corruption, in part by maintaining a powerful military.

Since then, however, two things have become clear. First, Putin has delusions of grandeur. Second, Russia is even weaker than most people, myself included, seem to have realized.

It has long been obvious that Putin desperately wants to restore Russia’s status as a Great Power. His already infamous “there is no such thing as Ukraine” speech, in which he condemned Lenin (!) for giving his neighbor what Putin considers a false sense of national identity, made it clear that his aims go beyond recreating the Soviet Union — he apparently wants to recreate the czarist empire. And he apparently thought that he could take a big step toward that goal with a short, victorious war.

So far, it hasn’t worked out as planned. Ukrainian resistance has been fierce; Russia’s military has been less effective than advertised. I’ve been especially struck by reports that the early days of the invasion were hampered by severe logistical problems — that is, the invaders had a hard time providing their forces with the essentials of modern war, above all fuel. It’s true that supply problems are common in war; still, logistics is one thing advanced nations are supposed to be really good at.

But Russia is looking less and less like an advanced nation.


The truth is that I was being generous in describing Russia as even a medium-size power. Britain and France are medium-size powers; Russia’s gross domestic product is only a bit more than half as large as either’s. It seemed remarkable that such an economically underweight state could support a world-class, highly sophisticated military — and maybe it couldn’t.

That’s not to deny that the force ravaging Ukraine has immense firepower, and it may well take Kyiv. But I wouldn’t be surprised if post-mortems on the Ukraine war eventually show that there was a lot more rot at the heart of Putin’s military than anyone realized.

And Russia is starting to look even weaker economically than it did before it went to war.

Putin isn’t the first brutal dictator to make himself an international pariah. As far as I can tell, however, he’s the first to do so while presiding over an economy deeply dependent on international commerce — and with a political elite accustomed, more or less literally, to treating Western democracies as their playground.

For Putin’s Russia isn’t a hermetic tyranny like North Korea or, for that matter, the old Soviet Union. Its standard of living is sustained by large imports of manufactured goods, mostly paid for via exports of oil and natural gas.

This leaves Russia’s economy highly vulnerable to sanctions that might disrupt this trade, a reality reflected in Monday’s sharp plunge in the value of the ruble despite a huge increase in domestic interest rates and draconian attempts to limit capital flight.

Before the invasion it was common to talk about how Putin had created “fortress Russia,” an economy immune to economic sanctions, by accumulating a huge war chest of foreign currency reserves. Now, however, such talk seems naïve.

What, after all, are foreign reserves? They aren’t bags of cash. For the most part they consist of deposits in overseas banks and holdings of other governments’ debt — that is, assets that can be frozen if most of the world is united in revulsion against a rogue government’s military aggression.

True, Russia also has a substantial amount of physical gold held within the country. But how useful is this gold as a way to pay for things the Putin regime needs? Can you really conduct large-scale modern business with ingots?

Finally, as I noted last week, Russia’s oligarchs have stashed most of their assets overseas, making them subject to freezing or seizure if democratic governments can muster the will. You might say that Russia doesn’t need those assets, which is true. But everything Putin has done in office suggests that he considers it necessary to buy oligarchs’ support, so their vulnerability is his vulnerability.

Incidentally, one puzzle about Russia’s pre-Ukraine image of strength was how a kleptocratic regime managed to have an efficient, effective military. Maybe it didn’t?

Still, Putin has one remaining ace in the hole: Feckless policies have made Europe deeply dependent on Russian natural gas, potentially inhibiting the West’s response to his aggression.

But Europe mainly burns gas for heat; gas consumption is 2.5 times higher in the winter than it is in the summer. Well, winter will soon be over — and the European Union has time to prepare for another winter without Russian gas if it’s willing to make some hard choices.

As I said, Putin may well take Kyiv. But even if he does, he will have made himself weaker, not stronger. Russia now stands revealed as a Potemkin superpower, with far less real strength than meets the eye.

https://www.nytimes.com/2022/02/28/opinion/pu...e9f650852d
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 75

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 102

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading
Aurora Innovation Faces Legal Probe After Stock Plunge

Updated Category News Views 80

Aurora's Troubles Draw Legal Scrutiny Looks like Aurora Innovation’s in the hot seat again, and not in a good way. When you see Kessler Topaz Meltzer & Check, LLP throwing their name into the mix, you know it’s getting serious. This legal eagle firm is poking around, seeing if Aurora stepped over the line with investors after their latest stumble—a production delay...

Continue Reading
Wonder Create: Democratizing Restaurant Creation

Updated Category News Views 112

Breaking Down Barriers in the Restaurant Industry It's been a long time since someone truly shook up the restaurant scene like this. Wonder Create is stepping in to turn anyone with a wild food idea into a bonafide restaurateur. We're not talking about the ol' franchising route here. We're diving straight into democratizing the culinary world. You seen something this bold...

Continue Reading
Universal Haptics Protocol May Cut Integration Friction

Updated Category News Views 291

A controller rumbling at the wrong moment is a small annoyance, but the plumbing behind that rumble has been a stubborn mess for years. The Haptics Industry Forum's Universal Haptics Protocol 1.0, announced November 17, 2026, is an attempt to clean up that mess with a shared language between software and touch-feedback hardware. This is not the sort of release that sends...

Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial

Updated Category News Views 22

Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...

Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays

Updated Category News Views 65

A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...

Continue Reading
InPHRED's Award Brings 1310 nm VCSELs Into Focus at IEEE

Updated Category News Views 64

A stubborn mirror problem just put InPHRED on the photonics map. InPHRED, founded in 2023, took the Best Technology award at the inaugural 2026 IEEE Photonics Conference Start-Up Competition, selected from seven finalists. That is a meaningful industry pat on the back, particularly because the company is aiming at a real engineering headache rather than waving around...

Continue Reading
Hanon's BMW Thermal Win Matters Beyond the Trophy Case Today

Updated Category News Views 11

A 16-Kilogram Box Just Grabbed the Auto Supply Chain’s Attention Hanon Systems did not win these two 2026 PACE honors by polishing up some old hose-and-valve package. Its Highly Integrated Cooling Entity, or HICE, is aimed right at a stubborn electric-vehicle problem: keeping a vehicle’s thermal systems controlled without turning the architecture into a sprawling,...

Continue Reading
Madrigal Pharmaceuticals Faces Legal Scrutiny Over Data

Updated Category News Views 71

Legal Storm Brews for Madrigal Pharmaceuticals Watch out, here comes another storm for Madrigal Pharmaceuticals, folks. This ain't no small drizzle either; it's a full-on legal monsoon, and it's soaked straight through the walls of their executive suite. We're talking a whistleblower sending alarm bells ringing about data fudging and some dodgy boardroom maneuvers—as if...

Continue Reading

Top 5 Most Recently Viewed Articles

TriPost Partners with Brixton Capital for Retail Expansion

Updated Category News Views 254

Strategic Partnership between TriPost and Brixton Capital TriPost Capital Partners, a real estate private equity firm, is thrilled to announce a significant partnership with Brixton Capital for acquiring a grocery-anchored retail portfolio. This collaboration focuses on high-quality investment opportunities in rapidly developing markets. Details of the Portfolio...

Continue Reading
Archer Aviation: Pioneering A New Era in Defense Technology

Updated Category News Views 200

Archer Aviation: A New Vision for Military Transportation When considering groundbreaking advancements in transportation, one might think of popular electric cars, but now there's a fresh contender: Archer Aviation Inc. This company stands out in the realm of electric vertical takeoff and landing aircraft (eVTOL), showcasing a vision that aligns with modern defense needs....

Continue Reading
Understanding Civil Claims for Rideshare Sexual Assault Victims

Updated Category News Views 279

Understanding Civil Claims for Rideshare Sexual Assault Victims Victims of sexual assault during rideshare trips have avenues to seek justice and compensation. With cases involving rideshare companies like Uber and Lyft, survivors might find themselves facing challenging circumstances after an assault. Fortunately, there are legal options available for those affected by...

Continue Reading
Ramsay Santé Optimizes Debt Structure with New TLB Reppricing

Updated Category News Views 242

Ramsay Santé Successfully Reprices Term Loans for Financial Growth Ramsay Santé recently achieved a significant milestone by repricing its €1,025 million Term Loan B4 (TLB4) and extending its €425 million Term Loan B3 (TLB3), effectively consolidating them into a new Term Loan B5. This strategic move is set to enhance their financial standing as part of their...

Continue Reading
NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading